Get startedLog in
    Picture of Sichuan Kelun-Biotech Biopharmaceutical logo

    6990 — Sichuan Kelun-Biotech Biopharmaceutical News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapHigh Flyer
    All News

    Brief: Sichuan Kelun-Biotech Says Cetuximab N01 Injection Approved For Marketing By NMPA China

    Picture of Sichuan Kelun-Biotech Biopharmaceutical logoSichuan Kelun-Biotech Biopharmaceutical
    07/02/2025 17:23
    Feb 7 (Reuters) - Sichuan Kelun-Biotech
Biopharmaceutical Co Ltd  6990.HK :
    * CETUXIMAB N01 INJECTION APPROVED FOR MARKETING BY NMPA
CHINA


Further company coverage:  6990.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Sichuan Kelun-Biotech Biopharmaceutical

    See all news